Craig Fraser insider trades

Open-market stock purchases and sales by Craig Fraser, President and CEO at Windtree Therapeutics Inc /de/, from SEC Form 4 filings since Sep 4, 2012.

Recent trades

No open-market trades in the last 12 months.

Companies traded

WINT Windtree Therapeutics Inc /de/: 33 buys, last Oct 8, 2024
DSCO Discovery Laboratories Inc /de/: other filings, last Feb 1, 2016
AEGR Aegerion Pharmaceuticals, Inc: 17 sales, last Apr 1, 2015

Get free alerts when Craig Fraser files a new trade →